Technology Sectors

Market Sectors

CBRNE | Detection

Explosives expert joins Worldwide Counter Threat Solutions

FREDERICKSBURG, VA Sept. 8, 2016 Worldwide Counter Threat Solutions, a leading, global provider of training and consulting solutions in capacity building, explosives safety and ammunition management, exploitation, forensics and biometrics, EOD/C-IED missions support and intelligence services, announced today that Larry Miyamoto has joined Worldwide Counter Threat Solutions as their Explosive Ordnance Disposal (EOD) Subject Matter Expert.

After a distinguished career in the United States Marine Corps, Larry analyzed the training and counter terrorism market sector and decided to apply his 31 years’ of experience with a Service-Disabled Veteran-Owned Small Business that understands the importance of combatting terrorist and extremist threats. “I’ve made the right choice,” said Larry. “This company facilitates advancing the capabilities of organizations that know they must be sharper than the threat.” Larry will direct operations and develop advanced solutions for Worldwide Counter Threat Solutions customers to achieve the overall success in defeating terrorist and extremist threats around the world.

“We are thrilled to welcome Larry to the Worldwide Counter Threat Solutions team and are excited to have him as the operations lead for our training mission support line of business,” said Joe Szymczak, CEO and President of Worldwide Counter Threat Solutions. “Larry brings a wealth of leadership, experience, and knowledge from a diverse array of missions and operations and is recognized as one of the nations’ leading experts in all areas of preparedness training.”

The 1991 graduate of the Naval EOD School contributed to the Joint EOD mission as a technician and Limited Duty Officer for 25 years. His assignments around the world cultivated his expertise in emergency response, consequence management, Counter-Improvised Explosive Device Operations, Chemical, Biological, Radiological, and Nuclear Operations and is a recognized expert in Combatting Weapons of Mass Destruction. In 2016, Larry completed his Project Management Professional certification before joining the team.

About Worldwide Counter Threat Solutions

Worldwide Counter Threat Solutions is a Service-Disabled Veteran-Owned Small Business (SDVOSB) with front-line expertise in delivering training solutions in more than 50 countries. Our capabilities help military organizations, government agencies, law enforcement and commercial organizations understand, prepare for and prevent terrorist attacks. We achieve our mission with an unwavering commitment to supporting our customer’s objectives with results-driven solutions delivered by a team of highly skilled subject matter experts. In today’s volatile and socio-political world, this suite of services is playing an ever-important role. For more information, visit our website at http://www.ww-cts.com.

Mobile counter-terror decision system now includes database of 167,000 CBRE threats

CASTRO VALLEY, CA Sept. 7, 2016 Supporting responders in the war on terrorism, Alluviam's HazMasterG3 decision support system Version 20 is now available. The system now includes critical new tools and major updates to key guidance when responding to chemical, biological, radiological or explosive threats. Enhanced sensor integration provides key insights into what is likely being made from a set of chemicals found in a clandestine lab.

Building on the best practices taught by Tom Gersbeck in his book "Practical Military Ordnance Identification", HazMasterG3 now includes interactive tools and checklists to provide responders, certified public safety bomb technicians and explosive ordnance disposal teams with enhanced guidance when called upon to identify threats posed by military ordnance. Additionally, more than 10,000 fields within HazMasterG3, with a total database of over 167,000 chemical, biological, radiological and explosive threats have been updated, assuring that responders have the most up-to-date guidance available. Updated mixture algorithms provide enhanced insights when predicting chemical reactions, mixture outcomes or attempting to attribute a specific set of chemicals to a specific narcotic, chemical warfare agent or explosive formulation.

This release also includes free tools to let organizations leverage facility pre-plans, known as Tier2 plans, on their mobile devices directly within HazMasterG3 without depending on any internet access or third party services – key when responding to major incidents that may degrade remote communications.

About Alluviam LLC

Founded in 2002, Alluviam LLC challenges the status quo of what's expected from a decision support system by delivering unique actionable insights unavailable on any other mobile platform. Adopted by the US Military, NATO, coalition partners and other civilian, intelligence and military agencies, HazMasterG3 puts state-of-the-art decision support in the hands of those that need it most. Only HazMasterG3 provides full capabilities on MS-Windows, or as an app on Android and iOS smartphones and tablets. HazMasterG3®, our flagship product, and its associated patented technologies have earned certification and designation by the U.S. Department of Homeland Security as an approved product for homeland security as the only mobile anti-terrorism technology of its kind.

Surgeons association journal articles warns U.S. lacks ability to detect radiation fallout

TUCSON, AZ Sept. 1, 2016 At the end of the Cold War, the U.S. buried its preparations for a nuclear attack, but there is a growing threat today of radiological emergency. Evidence includes Russia is building new underground nuclear command posts and adopting a new defense doctrine that calls for a possible nuclear response to a conventional threat. In the fall issue of the Journal of American Physicians and Surgeons, Arthur Levy writes that threats include radiological dispersal devices (RDDs or "dirty bombs"), improvised nuclear devices (INDs), and strategic nuclear warheads carried by advanced delivery systems such as ballistic missiles.

Today, most U.S. radiological instruments are designed for interdiction—discovering a device before it explodes. These instruments are highly sensitive and could detect such a device at a distance closer than about 50 feet, Levy states. After an explosion, however, different instruments are needed with a much higher dose range.

A copy of the article is available at: http://jpands.org/vol21no3/levy.pdf

Levy describes the Environmental Protection Agency's RadNet system, with some 135 fixed stations and a few dozen deployable stations, and the RadResponder Network, a collaborative effort by the Federal Emergency Management Agency (FEMA) and other agencies. Currently lacking are automated stations that continuously monitor for both "cloudshine" and "groundshine" over a very broad dosage range. Such stations are available at very affordable cost, but so far government has not recognized the need.

Agencies seem to believe that "it can't happen here," Levy observes.

The catastrophic impact of a nuclear explosion is well described. Less often discussed is that thousands or potentially millions of lives could be preserved by providing real-time radiation measurements that aid in preventing panic or warning the public of the need for shelter, the article notes.

The Journal of American Physicians and Surgeons is published by the Association of American Physicians and Surgeons (AAPS), a national organization representing physicians in all specialties since 1943.

California prisons chooses Metrasens solution to identify contraband

LISLE, IL Aug. 31, 2016 California Department of Corrections and Rehabilitation (CDCR) will be receiving 272 CellsensePLUS cell phone and contraband detection systems over the next eight weeks. These units, which are being provided by Metrasens, in conjunction with Global Tel*Link (GTL), will help detect prison contraband, namely cell phones, blades, razors and other items.

“We are delighted CDCR has selected Metrasens as a partner in the fight against contraband”, notes Jim Viscardi, Vice President, Security Division for Metrasens. “We’re confident Cellsense, a system with the highest levels of detection performance and versatility, will serve as an effective tool in their mission to protect the public through the safe and secure supervision of offenders.”

CellsensePLUS from Metrasens is the most durable, versatile and effective tool in the industry for finding cell phones, weapons and contraband. While the system has an unsurpassed record of finding cell phones, on or off, outside or inside the body, it's also capable of finding even the smallest contraband items, including shanks, razor blades, paper clips and staples. Whether freestanding or wall-mounted, CellsensePLUS is effective for screening inmates, staff, visitors, vendors, mattresses, mail, laundry and inmate belongings in virtually any part of a correctional facility.

About Metrasens

Metrasens is the expert and global leader in the development and application of advanced magnetic detection technologies in healthcare and security markets. Metrasens' Cellsense® product line leads the world in the important challenge of providing effective detection of smuggled contraband in correctional facilities. Metrasens is also the leading global provider of ferromagnetic detection Systems (FMDs) for MRI safety. The Ferroguard® product line is helping to keep patients and staff safe from ferromagnetic projectile hazards in healthcare facilities.

With a Technology & Manufacturing Centre in the UK and North American Sales & Support in Chicago, Metrasens products are available directly through direct sales representatives and a worldwide network of distributors and installers. For more information, please go to metrasens.com.

CANARY bio-threat system on display at postal convention

LAS VEGAS Aug. 23, 2016 Baltimore bio tech firm, PathSensors, Inc., announced that it will be leading a presentation on the CANARY® (Cellular Analysis and Notification of Antigen Risks and Yields) bio-threat detection technology at the MailCom 2016 Convention. Developed by scientists at MIT Lincoln Labs, CANARY can detect a wide range of threats such as anthrax and ricin faster, with greater sensitivity and more cost-effectively than alternative threat detection methods.

“Industry experts estimate that the loss of a single business day due to an incident such as a suspicious powder can cost businesses and governments hundreds of thousands of dollars,” commented Ted Olsen, CEO of PathSensors. “Given these potential costs, it is critical that mail room screening for threats such as anthrax is fast and accurate.” Mr. Olsen continued, “PathSensors has evaluated multiple solutions for mail screening threat detection, and no other technology is better than CANARY in terms of low false alarms, speed, low cost and ease of use.”

The CANARY technology was developed by scientists at MIT Lincoln Labs. It has been successfully deployed for mail room bio threat detection applications for large government agencies and commercial organizations. J.J. Lehett, PathSensor’s Director of Engineering will present data at the MailCom convention on a series of independent U.S. government tests of CANARY that demonstrate its performance.

“We understand that detection of bio threats in mail – whether in a high volume mail processing environment or in individual testing of suspicious powders can be challenging and potentially expensive,” said Mr. Lehett. “MailCom is an ideal opportunity for us to share our data on CANARY technology and discuss why we believe it should be considered by anyone concerned about the security of mail.”

About PathSensors, Inc.

PathSensors is a leading biotechnology solutions and environmental testing company. PathSensors provides high speed, highly sensitive pathogen and threat detection solutions for the defense, homeland security, public health, medical countermeasures, mail room screening, first responder, food processing and agricultural sectors. PathSensors’ innovative BioFlash and Zephyr detection systems use CANARY® technology licensed from the MIT-Lincoln Laboratory and are deployed by government and commercial agencies due to their speed, accuracy and ease-of-use. For more information, visit http://www.pathsensors.com.

ChemInage receives second option on Army chemical detection contract

PITTSBURGH, Aug. 23, 2016 ChemImage Sensor Systems (CISS) announced that the US Army has exercised the second option under its Next Generation Chemical Detector (NGCD) contract. Under the Option, CISS will design, fabricate and test Final Prototype sensors designed to detect and locate chemical warfare agents (CWA) on environmental surfaces. This work will be done under the direction of the Joint Project Manager for Nuclear, Biological, and Chemical Contamination Avoidance (JPM-NBC-CA).

Under the Option, CISS will continue the refinement of its portable hyperspectral imaging technology for CWA detection and produce Final Prototypes that will be evaluated by the Government for both operational utility and CWA detection performance. "The award of this Option enables CISS to build on the work performed in the Breadboard and Brassboard phases of the Program and get one step closer to fielding reliable and novel surface contamination detection sensors," stated CISS Project Manager, Charles W. Gardner, Ph.D., PMP.

"Proliferation of CWA continues to be a problem in our world," stated Marie Molnar Hammond, Vice President of Marketing and CISS Business Director. "We are pleased to continue our interaction with the U. S. Army to provide handheld instruments that dramatically lessen the warfighter impact of these terrible weapons of mass destruction."

Visit ChemImage Sensor Systems online: www.cisensorsytems.com

About ChemImage Sensor Systems

ChemImage Sensor Systems (CISS™) develops innovative standoff chemical imaging sensors that make our world healthier and safer by utilizing patented imaging capabilities and leverage current in-the-field technologies to address the ever-changing landscape of drugs, chemical, biological and explosive (CBE) threats. CISS has developed a series of chemical imaging sensors for point, proximity, remote and standoff detection and identification in both fixed site and on-the-move configurations, in order to protect military troops, security personnel and citizens. For more information, visit www.cisensorsystems.com

ChemImage Sensor Systems is a subsidiary of ChemImage Corporation, a leader in chemical imaging technology and instrumentation.

About ChemImage Corporation

ChemImage Corporation, a leader in hyperspectral and Raman chemical imaging technology provides innovative instrumentation, analysis software, contract services and expert consulting to government, industrial and academic organizations. The company's proprietary, state-of-the-art chemical imaging sensors make our world healthier and safer through many scientific applications, including defense, security, pharmaceuticals, forensic science and biomedical diagnostic research, which can reveal critical chemical and biological information from a variety of material systems. For more information, visit www.chemimage.com

ChemImage's headquarters are located in Pittsburgh, PA, where it pioneers research and development, as well as providing engineering and manufacturing which develops innovative products for the global marketplace.

 

FDA authorizes labs to use Zika detection kit by InBios

Seattle Aug. 19, 2016 InBios announced today that it received an Emergency Use Authorization (EUA) from the FDA for its ZIKV Detect™ IgM Capture ELISA. The product is intended for the presumptive detection of Zika virus IgM antibodies in human sera collected from individuals meeting CDC Zika virus clinical criteria (e.g., a history of clinical signs and symptoms associated with Zika virus infection) and/or CDC Zika virus epidemiological criteria. This important diagnostic test kit contains all the necessary reagents to perform this assay and obtain results in four hours or less. Additional testing is required to confirm positive results from this assay.

The ZIKV Detect™ IgM Capture ELISA is not cleared or approved by the FDA. It is now available for use in laboratories in the United States that are certified under the Clinical Laboratory Improvement Amendments of 1988 (CLIA), 42 U.S.C. §263a, to perform high complexity tests, or by similarly qualified non-U.S. laboratories, as a part of a multi-test CDC recommended testing algorithm. As one of the conditions of authorization outlined by FDA, InBios will report any suspected false negative results of which it becomes aware to the FDA.

This test has been authorized only for the diagnosis of Zika virus infection and not for any other viruses or pathogens. This test is only authorized for the duration of the declaration that circumstances exist justifying the authorization of the emergency use of in vitro diagnostic tests for detection of Zika virus and/or diagnosis of Zika virus infection under section 564(b)(1) of the Act, 21 U.S.C. § 360bbb-3(b)(1), unless the authorization is terminated or revoked sooner.

Wendy Bagnato, Senior Marketing Manager of InBios said, “One of the challenges with developing a serology kit for Zika is the likelihood of cross reactivity with other flaviviruses such as dengue. This can be a particular problem for patients living in or returning from areas where both Zika and dengue (or other flaviviruses) are endemic, making it difficult to determine the status of the patient. InBios’ kit has been designed to differentiate between the possibility of Zika virus and other flaviviruses, thus providing an important diagnostic tool for clinicians. We are very pleased to be able to offer this high quality kit in time to fill the critical demand in the US and its territories. We are acutely aware of the devastating effect this disease is having on pregnant women and believe this test will aid clinicians to diagnosis Zika virus infection faster.”

About Zika virus:

Zika virus is a disease which is spread to people primarily through the bite of an infected mosquito (Aedes aegypti and Aedes albopictus). The most common symptoms of Zika virus disease are fever, rash, joint pain, and red eyes. Other symptoms include muscle pain and headache. Many people infected with Zika virus won’t have symptoms or will have mild symptoms, which can last for several days to a week.

Complications:

An infected pregnant woman can pass Zika virus to her fetus during pregnancy or at the time of birth. Also, individuals infected with Zika virus can pass it to sex partners. Zika virus infection during pregnancy can cause a serious birth defect called microcephaly and other severe brain defects. Guillain-Barre syndrome (GBS), an uncommon sickness of the nervous system, is also very likely triggered by Zika virus infection in a small number of cases.

Recent Outbreaks:

Zika virus outbreaks may have occurred in many locations previously but have gone unrecognized because the symptoms are similar to other diseases such as dengue and chikungunya viruses. In May 2015, the Pan American Health Organization (PAHO) issued an alert regarding the first confirmed Zika virus infection in Brazil and on February 1, 2016, the World Health Organization (WHO) declared Zika virus a public health emergency of international concern (PHEIC). Local transmission has been reported in Americas, including recently in the United States. The U.S. has declared a Public Health Emergency in the U.S. territory of Puerto Rico due to the large number of ZIKA cases.

For more information on Zika virus, visit the CDC website: https://www.cdc.gov/zika/index.html

About InBios International, Inc.

InBios International, Inc., located in Seattle, WA, USA develops and manufactures high-quality proprietary diagnostic tests for infectious diseases. The facility is USDA licensed, FDA registered and ISO 13485:2003 Certified. InBios develops and markets a full range of diagnostic products affecting global public health including its FDA cleared Dengue Detect™ IgM Capture ELISA and West Nile Detect™ IgM Capture ELISA. The company also offers a full range of CE marked products including a Chikungunya ELISA kit. All products are manufactured in the USA.

Visit the InBios website: http://www.inbios.com.

Alpha Diagnostic International developing test kits to detect MERS viral infections

SAN ANTONIO Aug. 17, 2016 The Middle East Respiratory Syndrome (MERS) outbreak over the past several years has created an urgent need for diagnostic and therapeutic solutions. Alpha Diagnostic International, Inc. (ADI) has developed multiple ELISA test kits for screening MERS virus infections. These test kits will greatly enhance the ability to screen and quarantine humans and other animal species suspected of being infected by the MERS virus and become an important diagnostic tool for the health community as they work to combat further spread of the disease. For additional details on MERS-CoV related products, please visit: http://4adi.com/objects/catalog/product/extras/MERS_Vaccine_ELISA_Flr.pdf

MERS is a viral respiratory infection suspected to be derived from bats. MERS symptoms can range from asymptomatic to severe or even lethal. MERS infected individuals exhibit a high fatality rate with about a third of confirmed cases succumbing to death. What was first identified as an outbreak restricted to countries within the Arabian Peninsula has now shown up in several other Asian countries. The largest outbreak outside of Saudi Arabia was in South Korea in May of 2015 with 36 confirmed deaths and several thousand individuals quarantined. In total worldwide, there have been 1,791 confirmed cases of MERS-CoV, 640 MERS-CoV related deaths, and 27 affected countries.

“ADI has recognized the urgency and importance of developing diagnostic reagents to test for potential viral infection since the very first outbreak in the Middle East during 2012,” says Dr. Masarrat Ali, Scientific Director and President of ADI. “ADI has cloned and expressed various MERS recombinant proteins, made antibodies, and developed various ELISA kits to detect antibodies in animals and humans. ADI is the first company to introduce commercial ELISA kits to detect antibodies in humans, camels, and many other species,” added Dr. Ali.

The MERS ELISA kits developed by ADI allow for the testing of 96 samples using a single kit; each kit contains all reagents and positive and negative controls to perform the tests. These kits have been developed for testing samples in humans, camels, bats, pigs, cows, goats, and sheep. For each species, there are 3 different kits available for testing antibodies against nucleoprotein, spike protein 1, and spike protein 2.

About Alpha Diagnostic International, Inc.: ADI is a privately held, U.S. biotechnology company headquartered in San Antonio, Texas. ADI develops, manufactures, and supplies novel diagnostic and quality control reagents and test kits for use in basic biological and disease research in humans and animals. An important mission of ADI is to develop and supply diagnostic and validating solutions for promoting global health through improved vaccine therapeutics and mitigating the spread of human and animal diseases. For additional details, please visit: http://www.4adi.com.

Smiths Detection wins contract to provide detection systems at Egyptian airports

WIESBADEN, Germany Aug. 10, 2016 Smiths Detection has been awarded contracts worth almost £19m by Falcon Group to provide advanced detection systems for passenger checkpoint, hold baggage and cargo screening to airports across Egypt.

The award for X-ray scanners, people screening systems and trace detectors is part of national programme to provide an additional layer of security to existing equipment at airports. Smiths Detection systems were chosen by the Egyptian Ministry of Defence for their lifetime high performance and quality, as proven by earlier contracts.

The HI-SCAN 6040aTiX and HI-SCAN 6040-2is HR, which combine multi- or dual-view, high resolution imaging with sophisticated software to automatically detect explosives in carry-on baggage, will be deployed at security checkpoints. The innovative millimeter-wave eqo scanners, which can detect threat items of any material under clothing, will provide additional passenger screening. The recently launched IONSCAN 600, which detects and identifies explosives from traces found on baggage or clothing, will be deployed at passenger checkpoints and in hold baggage screening.

The contract also includes HI-SCAN 100100T-2is and HI-SCAN 145180-2is X-ray machines for screening oversized baggage and air cargo for explosives and other threats. Additional vehicle and cargo screening will be provided by the CIP-300 and HCVP Z60 car inspection X-ray portals and the mobile HCVMe35 for the inspection of loaded trucks and containers at airport entrances. Deliveries will be completed by August 2016.

Falcon Group is the main security supplier for Egypt and is in close relationship to the Military Intelligence which is a part of the Egyptian Ministry of Defence.

Tony Tielen, Regional Vice President EMEA, at Smiths Detection, said: “Enhancing aviation security through leading-edge technology is our top priority. With a broad portfolio of detection technologies, an excellent customer-orientated sales team and a strong local partner, ITI, we are proud to be a trusted partner of the Egyptian Ministry of Defence. The range of screening systems included in this contract will help provide world-class detection capabilities to protect against evolving threats.”

Smiths Detection offers advanced security solutions in civil and military markets worldwide, developing and manufacturing government-regulated technology products that help detect and identify explosives, chemical and biological agents, radiological and nuclear threats, weapons, narcotics and contraband. It is part of Smiths Group, a global leader in applying integrated, advanced technologies to markets in threat and contraband detection, energy, medical devices, communications and engineered components. Smiths Group employs around 23,000 people in more than 50 countries.

Read all the latest news from Smiths Detection, follow us on LinkedIn at www.linkedin.com/company/smiths-detection, YouTube at www.youtube.com/user/smithsdetectiongroup, and Twitter at twitter.com/smithsdetection.

New feature in CISS mail screeners can detect narcotics

PITTSBURGH, Aug. 2, 2016 ChemImage Sensor Systems (CISS™) announced the launch of a new Presumptive Identification feature for their VeroVision™ Mail Screener product. The VeroVision Mail Screener, which was introduced to the corrections market in April 2015, is a non-contact imaging device designed to detect concealed narcotics that are sent through the mail to inmates. CISS will debut the VeroVision Mail Screener's presumptive identification capability at the upcoming American Correctional Association 146th Congress of Corrections in Boston, MA, from August 5th -10th, 2016. The VeroVison Mail Screener's current detection and new presumptive identification capabilities will be demonstrated at the CISS exhibit at booth #405.

The ChemImage VeroVision Mail Screener features a simple, one-click user interface that allows the operator to quickly and efficiently scan mail. Within seconds, the presence of an illicit drug and/or common cutting agent that may be hidden in a mail item is confirmed. And now, not only will the system detect the illicit material; it will give you a presumptive identification of what that material is. These detections/presumptive identifications are presented to the user in a simple interface which allows for report generation, inclusive of images.

In addition to demonstrating the Mail Screener's detection capability and officially introducing its Presumptive Identification capability, as a part of the expo, ChemImage Sensor Systems is hosting a hospitality event after sessions on Monday, August 8th, 2016 at Kings in Boston. Attendees to the expo have been invited to the CISS event for a fun-filled night of games, amusement, and other surprises to celebrate our continued success with the VeroVision Mail Screener and the launch of the Presumptive Identification feature.

For more information on the VeroVision Mail Screener product or ChemImage Sensor Systems you can visit them during the ACA conference or on their website www.cisensorsystems.com.

About ChemImage Sensor Systems

ChemImage Sensor Systems (CISS™) develops innovative standoff chemical imaging sensors that make our world healthier and safer by utilizing patented imaging capabilities and leverage current in-the-field technologies to address the ever-changing landscape of drugs, chemical, biological and explosive (CBE) threats. CISS has developed a series of chemical imaging sensors for point, proximity, remote and standoff detection and identification in both fixed site and on-the-move configurations, in order to protect military troops, security personnel and citizens. For more information, visit www.cisensorsystems.com

ChemImage Sensor Systems is a subsidiary of ChemImage Corporation, a leader in chemical imaging technology and instrumentation

About ChemImage

ChemImage Corporation, a leader in hyperspectral and Raman chemical imaging technology provides innovative instrumentation, analysis software, contract services and expert consulting to government, industrial and academic organizations. The company's proprietary, state-of-the-art chemical imaging sensors make our world healthier and safer through many scientific applications, including defense, security, pharmaceuticals, forensic science and biomedical diagnostic research, which can reveal critical chemical and biological information from a variety of material systems. For more information, visit www.chemimage.com

ChemImage's headquarters are located in Pittsburgh, PA, where it pioneers research and development, as well as providing engineering and manufacturing which develops innovative products for the global marketplace.

Pages

 

Recent Videos

IntraLogic's official release of the "One Button" Lockdown system on CBS 2 News.
HID Global is opening the door to a new era of security and convenience.  Powered by Seos technology, the HID Mobile Access solution delivers a more secure and convenient way to open doors and gates, access networks and services, and make cashless payments using phones and other mobile devices. ...
Mobile device forensics can make a difference in many investigations, but you need training that teaches you how to get the most out of your mobile forensics hardware and software, and certifies you to testify in court. Read this white paper to learn how to evaluate mobile forensics training...
PureTech Systems is a software company that develops and markets PureActiv, its geospatial analytics solution designed to protect critical perimeters and infrastructure.  Its patented video analytics leverage thermal cameras, radars and other perimeter sensors to detect, geo-locate, classify, and...